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Cerebral hyperperfusion syndrome is a rare, serious complication of carotid revascularization either after carotid
endarterectomy or carotid stent placement. Impaired cerebral autoregulation and post-revascularization changes in
cerebral hemodynamics are the main mechanisms involved in the development of the syndrome. Hyperperfusion
syndrome may be fatal once an intracranial hemorrhage occurs. This article reviews the literature, intending to make a
synthesis of all new data concerning the clinical manifestations of hyperperfusion syndrome, the pathophysiologic
pathways involved in its development, the prediction, and the appropriate management. Also, a review of the most recent
series of hyperperfusion syndrome following carotid revascularization, both with classic open endarterectomy and carotid
artery stenting has been performed. (J Vasc Surg 2009;49:1060-8.)Carotid endarterectomy (CEA) is still regarded as the
gold standard therapy for prevention of primary and sec-
ondary stroke in patients with significant carotid artery
disease while carotid stenting has been emerged as a poten-
tial alternative to carotid endarterectomy under certain
indications.1 Cerebral hyperperfusion syndrome (CHS) is a
relatively rare but potentially devastating event that can
complicate both techniques.2-7 In the worst case scenario,
hyperperfusion syndrome may be fatal once an intracranial
hemorrhage occurs.3,7-12
DEFINITION OF HYPERPERFUSION AND
CEREBRAL HYPERPERFUSION SYNDROME
Since Sundt described the combination of increased
arterial blood pressure with the clinical triad of ipsilateral
migraine-like headache, seizure, and transient focal neuro-
logic deficits in the absence of cerebral ischemia after a
successful CEA in 1981, the term cerebral hyperperfusion
syndrome (CHS) has been used to describe this clinical
entity.13 Spetzler had first described the phenomenon of
hyperperfusion three years earlier following surgical resec-
tion of arteriovenous malformations. He had used the
“theory of normal perfusion pressure breakthrough,” em-
phasizing the impaired cerebral autoregulation,which re-
mained after the fistulae resection.14
Various authors have supported the definition of the
syndrome based on the combination of the clinical picture
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1060with imaging techniques. In order to confirm the clinical
diagnosis, they have suggested as diagnostic imaging criteria
an increase in cerebral blood flow (CBF) compared with
preoperative or baseline values and/or the demonstration of
hyperperfusion on perfusion magnetic resonance imaging
(MRI) or computed tomography (CT) scans.3,4,15-23 The
presence of symptoms is essential in the definition of the
syndrome.
This last comment emphasizes a critical distinction
between hyperperfusion and hyperperfusion syndrome.
Hyperperfusion is defined as the increase in CBF, com-
pared to preoperative or baseline values, expressing a he-
modynamic parameter of cerebral circulation. Hyperperfu-
sion following CEA occurs in 0.2% to 18.9% of patients.2
Some patients, after carotid revascularization, demonstrate
only a modest increase in CBF, less than 100%.2 CHS is most
common in patients with CBF increases of more than 100%
compared with baseline values after carotid revascularization
and is rare in patients with increases in perfusion less than
100% comparedwith baseline values.2 In series byOgasawara,
Suga, and Fukuda (Table I), 16.7% to 28.6% of the patients
with an increase of CBF100% developed CHS.
Based on this finding, some authors have suggested
that this syndrome should also be called “reperfusion syn-
drome” rather than hyperperfusion syndrome, to reflect the
reperfusion injury effects.24 The key event in the expression
of syndrome seems to be a combination of increased cere-
bral blood flow (compared with preoperative levels) with
individualized disturbed cerebro-vascular autoregulation.
PATHOPHYSIOLOGY OF CHS
Two interlinked and synergistic mechanisms may lead
to increased CBF. First, impaired cerebral autoregulation
seems to play a significant role. The normal brain has the
perfus
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autoregulatory mechanisms, when a change in blood flow
occurs. Themain autoregulatorymechanism is the cerebro-
vascular reactivity, the ability of the arterioles to constrict or
dilate in response to the alterations of blood flow or to
other stimuli (ie, hypocapnia).25 Patients with extracranial
carotid stenosis often present exhausted cerebrovascular
reactivity. This situation represents a status of maximal
vasodilatation of cerebral arterioles, in order to maintain
sufficient cerebral blood supply, counterbalancing the re-
duced perfusion caused by a hemodynamically significant
carotid lesion.26
The severity of microvascular autoregulation impair-
ment may be dependent on the duration and intensity of
cerebral hypoperfusion; they are associated with the grade
of the ipsilateral carotid stenosis, the presence of contralat-
eral carotid occlusion, and poor collateral flow.21,27-30
However, the syndrome has also been described in the
absence of contralateral occlusion or severe stenosis, re-
flecting not a contradiction with the previous statement but
the significant role of disturbed cerebral autoregulation
that can be developed in the cerebral territory of ipsilateral
carotid stenosis even in the absence of contralateral lesion.
This consideration is confirmed by a recent study demon-
strating that patients with moderate carotid artery stenosis
may also have impaired dynamic cerebrovascular autoregu-
Table I. Incidence of hyperperfusion, cerebral hyperperfu
endarterectomy in the reviewed series from 2003 to 2008
Author Year
Patients
(n)
Definition of
hyperperfusion/CH
Ogasawara47 2007 1596 Acute neurological deter
in the immediate
postoperative period
Maltezos65 2007 100
Wagner84 2005 1602
Karapanayiotides24 2005 388
Fujimoto73 2004 95
Coutts3 2003 129
Fukuda71 2007 70 CBF increase of 100% co
with preoperative valu
assessed by PWI
Ogasawara 15 2005 67 CBF increase 100%, co
with preoperative valu
measuring BFV in MC
TCD or assessed by SP
images
Hosoda18 2003 41 CBF increase 100%, co
with preoperative valu
assessed by SPECT im
Yoshimoto19 2005 18
Suga20 2007 90
Komoribayashi75 2006 89
Ascher21 2003 404 Severe ipsilateral headach
seizures
Increased ipsilateral ICA
flow (100%) compar
intraoperative values
measured by TCD
Total 4689
BFV, Blood flow velocity; CEA, carotid endarterectomy; CHS, cerebral hy
MCA,middle cerebral artery; n.d., not determined; n.r., not reported; PWI,
computed tomography; TCD, transcranial Doppler.lation.30 Increased nitric oxide levels during clamping ofthe ICA and increased oxygen-derived free radicals pro-
duced during the restoration of the perfusion pressure are
involved in endothelium dysfunction and the deterioration
of autoregulatorymechanisms after CEA.20 Besides, several
studies have demonstrated significant elevations in malon-
dialdehyde, diene conjugates, or lipoperoxides, products of
free radical-induced lipid peroxidation, in jugular vein
plasma immediately after declamping of the ICA in patients
undergoing CEA.31,32
The second significant mechanism in the pathogenesis
of hyperperfusion syndrome is postoperatively elevated sys-
temic blood pressure. Both hypertensive and hypotensive
alterations of blood pressure after carotid endarterectomy
have been reported in up to 66% of patients following
carotid endarterectomy.33 Although transient hypotension
and bradycardia can occasionally be observed due to stim-
ulation of the carotid body nerve,34 baroreceptor reflex
failure after receptor denervation during CEAmay contrib-
ute to hypertension after endarterectomy.33-35 Especially
after bilateral CEA, the baroreflex breakdown induced hy-
pertension leads to an increase of CBF; in contrast, auto-
regulation mechanisms are diminished and thus lead to
hyperperfusion in the previously hypoperfused tissue.33,35
Both cerebral hyperperfusion associated with cerebral
edema and elevated intracranial pressure may lead to an
syndrome, and intracranial hemorrhage after carotid
Patients with
hyperperfusion (%)
Patients with
CHS (%)
Patients with
ICH (%)
on n.d. 30/1596 (1.9%) 6/1596 (0.4%)
14/100 (14%) n.r.
6/1602 (0.4%) 3/1602 (0.2%)
5/388 (1.3%) 4/388 (1%)
12/95 (13%) n.r
4/129 (3.1%) 1/129 (0.8%)
ed 7/70 (10%) 2/70 (2.8%) n.r.
ed 7/67 (10.4%) 2/67 (3%) n.r.
ed 4/41 (9.8%) n.r. 0%
7/18 (11%) 2/18 (11%) n.d.
12/90 (13%) 2/90 (2.2%) n.d.
10/89 (11%) 2/89 (2.2%) n.d.
me
ith
n.r. 9/404 (2.2%) n.d.
47/375 (12.5%) 90/4648 (1.9%) 14/3756 (0.37%)
rfusion syndrome; ICA, intracranial artery; ICH, intracranial hemorrhage;
ion-weighted magnetic resonance imaging; SPECT, single-photon emissionsion
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sure.34
However, it is important to note that the mechanisms
of postoperative increase in blood pressure are not com-
pletely elucidated and could not be entirely attributed to
baroreceptor reflux failure. Other proposed mechanisms
include elevated cranial norepinephrine levels, suggestive of
a central nervous system sympathomimetic mechanism, the
release of vasoactive neuropeptides from perivascular sen-
sory nerves via axon reflex-like mechanisms, the periopera-
tive stress, and the use of specific anesthetic agents.36-41
Postoperative hypertension after carotid endarterectomy
seems to have a multifactorial etiology and, according to
the literature, its incidence, attributed to all etiologic mech-
anisms, ranges from 19% to 64%.36-41
Increased CBF, which can not be controlled by auto-
regulatory mechanisms, leads to transudation of fluid into
the pericapillary astrocytes and interstitium. This results in
vasogenic white matter edema, especially in the vertebro-
basilar circulation territory of the posterior parietal and
occipital regions.42 Histological findings, similar to those
of hypertensive encephalopathy, including hyperplasia of
endothelial cells, fibrinoid necrosis, and extravasation of
erythrocytes with petechial or breakthrough hemorrhages
have been also been described in patients with hyperperfu-
sion or CHS.42-45
REVIEW ANALYSIS OF REPORTED SERIES OF
HYPERPERFUSION AND CHS BETWEEN 2003
AND 2008
A multiple electronic health database search was per-
formed including Medline, Embase, Ovid, and Cochrane
Database of Systematic Reviews, on all articles published
between 2003 and 2008 and referring to cerebral hyper-
perfusion after carotid revasculization. The full text of the
studies was retrieved and was independently assessed by the
authors. Thirteen studies on hyperperfusion after CEA
were included with a total of 4689 patients and 9 studies on
hyperperfusion after CAS with a total of 4446 patients. The
incidence of CHS and ICH after CAS was 1.16% (range,
0.44% to 11.7%) and 0.74% (range, 0.36% to 4.5%), respec-
tively. CHS and ICH were observed in 1.9% (range, 0.4%
to 14%) and 0.37% (range, 0% to 1%) of reviewed patients
after CEA, respectively (Tables I and II). In addition, the
incidence of each clinical manifestation of CHS after CEA
was estimated by analyzing the available data from the
collected series (Table III).
CEREBRAL HYPERPERFUSION SYNDROME
AND INTRACRANIAL HEMORRHAGE
FOLLOWING CAS AND CEA
Hyperperfusion syndrome can complicate carotid re-
vascularization, after both classic open endarterectomy and
carotid artery stenting (CAS). The incidence of cerebral
hyperperfusion after CAS has not been extensively investi-
gated and only a small number of studies have been con-
ducted to estimate it.3,5-7,12,22,23,46 It is unclear if the risk
for CHS is comparable between CEA and CAS. Patientswho are referred for CAS are usually high risk patients
exhibiting many pre-procedural predisposing factors for
CHS; they are discussed later in the manuscript. Addition-
ally, endovascular treatment involves more aggressive anti-
coagulation protocols in combination with dual antiplatelet
therapy. Some authors claim that this extensive use of
anticoagulants and antiplatelet agents is associated with an
increased incidence of ICH following CAS, whereas others
do not assert any correlation.12,46
Ogasawara described two more differences in the de-
velopment of CHS and ICH following CAS and CEA.47
First, postoperative ischemic cerebral lesions due to emboli
aremore frequent after CAS than duringCEA.48 Following
the emboli resorption and the artery recanalization, cere-
bral hyperperfusion can occur leading to hemorrhagic
transformation in an unviable cerebral area. Additionally
carotid baroreceptor stimulation during CAS via a balloon
or a carotid stent induces transient, sometimes prolonged
bradycardia and hypotension that can result inmore intense
cerebral ischemia than during clamping of the ICA in CEA.
Furthermore, subsequent rebound arterial hypertension
may induce delayed cerebral hyperperfusion.5
CLINICAL PRESENTATION
Symptoms of CHS may occur up to several weeks after
revascularization but usually within the first few days (Table
III).2 Ogasawara suggested that the onset of CHS peaks on
the sixth postoperative day in patients who undergo CEA
and within 12 hours after surgery in those who undergo
CAS; this could be explained considering the above men-
tioned differences in CHS development after CEA and
CAS.47 Deterioration of consciousness, confusion, and
headache are the most common symptoms of CHS; head-
ache is usually moderate to severe, ipsilateral to the revas-
cularized artery, pounding, and migrainous.3 The neuro-
logic deficit of CHS, which is secondary to cerebral edema
is usually transient.8,9,15,27,45 It includes manifestations
derived from the cortex (ie, hemiparesis, hemiplegia, hemi-
anopsia, obtundation, and aphasia), and epileptic distur-
bances – focal motor seizures or seizures with further
generalization. Ataxia and visual disorders are less com-
mon. Miscellaneous symptoms such as cognitive impair-
ment and psychotic disorders have been also reported in
patients with CHS.49
The most catastrophic event that can occur secondary
to hyperperfusion is intracerebral hemorrhage (ICH). In-
tracerebral hemorrhage, as previously reported, occurs in
0.37% (range, 0% to 1%) of patients in large series of carotid
endarterectomy (CEA), and in 0.74% (range, 0.36% to
4.5%) in CAS (Tables I and II). Since intracerebral hemor-
rhage is associated with CHS, manifestations of increased
intracerebral pressure (eg, vomiting or altered sensorum)
can be present.4 It is important to note an ICH entity
following CAS, described as hyperacute ICH; it occurs
within hours. This type of ICH is less common but almost
always unpreventable (since it usually occurs without pro-
dromata) and fatal. The pathophysiologic mechanism of
this early variant of ICH involves rupture of the perforating
puted
PECT
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suddenly normalized perfusion pressure after CAS.50
RISK FACTORS AND PREDICTION OF
HYPERPERFUSION AND CEREBRAL
HYPERPERFUSION SYNDROME
Understanding of the pathophysiology of the hyper-
perfusion is multifactorial, while cerebral haemodynamics
and cerebral autoregulation, as previously mentioned, are
individualized in each patient. CBF changes after revascu-
larization vary, while there is no evidence directly linking
Table II. Incidence of hyperperfusion, hyperperfusion syn
stenting in the reviewed series from 2003 to 2008
Author Year Patients
Definition of hyperperfusio
ICH
Sfyroeras68 2008 29 - Neurological symptoms (h
or non hemispheric) assoc
hyperperfusion in brain SP
and increased MFV in the
MCA
Ogasawara47 2007 2898 - Severe headache, seizure,
deterioration of conscious
and/or development of fo
neurological
- Absence of any additional
lesion on magnetic resona
imaging performed on the
postoperative day;
- Postoperative increases in C
ipsilateral hemisphere exc
flow in the contralateral h
as measured using perfusi
photon emission CT or co
enhanced CT
- Postoperative increases in M
blood flow velocity of mo
100% of the preoperative
transcranial Doppler
ultrasonography.
Abou5 2007 836 - Ipsilateral headache with o
nausea and vomiting, ipsil
seizures, or focal neurolog
Kablak-Ziembicka6 2006 92 - Headache, seizures, focal n
deficits
du Mesnil de
Rochemont22
2006 50 - Neurologic deficits and vas
oedema on MR imaging
Imai23 2005 17 - Greater flow in the ipsilate
hemisphere than on the c
side assessed by SPECT im
Kaku53 2004 30 - CBF increase of 100% co
with the normal side
- Clinical symptoms as a resu
rapidly increased CBF
Abou12 2004 450 - Ipsilateral headache with o
nausea, vomiting, ipsilater
seizures, or focal neurolog
Coutts3 2003 44 - Hemispheric neurological
ipsilateral to the revascula
artery
Total 4446
CBF,Cerebral blood flow;CHS, cerebral hyperperfusion syndrome;CT, com
MFV, mean flow velocity; MR, magnetic resonance; n.d., not determined; Sthe CBFmodifications and the degree of stenosis.51,52 Thiscould be explained by the different extent of collateral
circulation available in each patient and by the autoregula-
tory mechanisms of the cerebral circulation stimulated after
the detection of the hyperperfusion. These changes are
hard to be explained only by the restoration of the patency
of a narrowed vessel; other autoregulatory mechanisms are,
probably, implied.
Although clinical studies have indicated a potential role
for various risk factors, definitive prediction of subgroups of
patients as those at increased risk of developing CHS after
CEA or CAS, is not feasible. This point expresses not the
e, and intracranial hemorrhage after carotid artery
S/ Patients with
hyperperfusion (%)
Patients with
CHS (%)
Patients with
ICH (%)
heric
with
scan
teral
n.d. 2/29 (6.9%) 0%
level,
ic
n the
g the
here,
gle-
non-
n
s on
n.d. 31/2898 (1.1%) 21/2898 (0.7%)
out
l focal
eficit
n.d. 8/836 (0.96%) 3/836 (0.36%)
logic n.d. 2/92 (2.2%) 2/92 (2.2%)
ic n.d. 1/50 (2%) 0%
lateral
4/17 (23.5%) 2/17 (11.7%) 2/17 (11.7%)
ed 3/30 (10%) 1/30 (3.33%) 0%
out
al
eficit
n.d. 2/450 (0.44%) 3/450 (0.67%)
t n.d. 3/44 (6.8%) 2/44 (4.5%)
7/47 (15%) 52/4446 (1.16%) 33/4446 (0.74%)
tomography; ICH, intracranial hemorrhage;MCA,middle cerebral artery;
, single-photon emission computed tomography.drom
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drome. Table IV describes risk factors, which have been
identified to be significantly involved in hyperperfusion
pathophysiological pathways and the development of CHS.
Preoperative variables such as low pulsatility index, severe
ipsilateral or contralateral carotid disease, bilateral carotid
artery stenosis, and an incomplete circle of Willis, increase
the risk of CHS.10,27-29 Abou and colleagues suggested
that the risk of CHS development was 16% for patients with
treated stenoses of  90% luminal narrowing or occlusion,
contralateral stenoses of  80%, and longstanding pre-
procedural hypertension.12 Additionally, one study sug-
gested that the interval between the procedures (in case of
bilateral carotid stenosis) is a predictive factor of CHS
development; incidence of CHS in patients underwent
recent contralateral CEA (3 months) was higher than in
patients who underwent the second procedure in longer
interval. The authors suggested that inconsistencies in
baroreceptor function may be a causative factor for CHS.21
Patient age, impaired cerebrovascular reactivity, mea-
Table III. Clinical presentation of hyperperfusion
syndrome in the reviewed series of Table I
Type of symptom Incidence
Deterioration of consciousness, confusion 37.1% (23/62)
Headache 30.6% (19/62)
Epileptic disturbances, focal seizures 25.8% (16/62)
Motor disturbances (hemiparesis, hemiplegia) 17.7% (11/62)
Abnormal speech, aphasia 6.4% (4/62)
Nausea 4.8% (3/62)
Intracranial hemmorage 4.8% (3/62)
Psychotic disorders 3.2% (2/62)
Visual disturbances (hemianopsia) 3.2% (2/62)
Ataxia 1.6% (1/62)
Table IV. Risk factors of hyperperfusion and cerebral
hyperperfusion syndrome
Preoperative
Long standing increased BP with hypertensive
microangiopathy
Diabetes mellitus
Increased age
Recent contralateral CEA (3 months)
High grade ipsilateral carotid stenosis with poor collateral flow
Contralateral carotid occlusion
Incomplete circle of Willis
Attenuated cerebrovascular reactivity after acetazolamide
challenge
Perioperative
Intraoperative distal carotid pressure of 40 mmHg
High doses of volatile halogenated hydrocarbon anesthetics
Periprocedural cerebral infarction
Intraoperative ischemia
Refractory postoperative cerebral hyperperfusion
Postoperative
Postoperative hypertension
Administration of anticoagulants or antiplatelet agents
BP, Blood pressure; CEA, carotid endarterectomy.sured preoperatively by assessing acetazolamide or breathholding, induced changes in cerebral blood flow, asymme-
try index, and preoperative CBF reduction have also been
suggested as significant predictors of hyperperfusion syn-
drome after CAS or CEA.21,26,53-56 Diseases that can result
in microangiopathy affecting endothelium of small vessels
(ie, diabetes mellitus or longstanding pre-existing hyper-
tension) have been found to predispose to hyperfusion and
CHS development.2,57
The use of anticoagulants and antiplatelet agents is
routine after CAS as well as after surgery. In the absence of
sufficient data, it remains uncertain whether the use of
post-procedure anticoagulation therapy may be associated
with an increased risk of developing CHS and ICH.12,58
INVESTIGATORY TECHNIQUES IN
PREDICTION AND DIAGNOSIS OF CHS
Several techniques have been applied to investigate
potential predisposing factors and identify patients at risk
for CHS. Transcranial Doppler (TCD) is the most widely
available method for predicting CBF changes by mesasur-
ing the cerebral blood flow velocity (CBFV) in intracranial
vessels.25 TCD has been used to assess cerebrovascular
reactivity using vasodilatory agents such as acetazolamide,
CO2 inhalation, or the breath holding test.
59-62 Carotid
revascularization procedures produce significant increase in
blood flow, by eliminating the severe narrowing of the
vessel. This results in an abnormal increase of mean flow
velocity of the MCA in patients with exhausted cerebrovas-
cular reactivity.59-62 Preoperative significant reduction in
flow velocity compared with baseline values is indicative of
hypoperfusion and is associated with postoperative hyper-
perfusion.63
Recent studies demonstrate that TCD has considerable
technical difficulties including an insufficient cranial win-
dow.16,24,64 Despite the technical difficulties and the level
of operator’s experience, findings of TCD should be criti-
cally evaluated as measurement of intracranial vessels veloc-
ities; they may depend on anatomic variants, the grade of
collateralization, and the presence of contralateral ICA
occlusion or stenosis.65 Only 18% to 54% of people have a
complete circle of Willis, while in patients considered for
CEA, the severity of the contralateral ICA disease is an
important determinant of the pattern of cerebral blood
flow redistribution. Results in TCD studies demonstrate
that blood flow redistribution, through the anterior com-
municating pathway and ophthalmic artery is achieved, in
case of contralateral ICA stenosis, and through the poste-
rior communicating pathway in patients with contralateral
ICA occlusion.65,66
Intraoperative distal internal carotid artery pressure
(dICAP) measurement has been proposed to predict the
occurrence of hyperperfusion after CEA; intraoperatively
low dICA (40 mm Hg) has a high predictive value for
postoperative hyperfusion.19 In addition, Asher reported a
significant increase in mean internal carotid artery volume
flow (MICAVF) in all patients with CHS during the symp-
tomatic period. In that study, the values were proportional
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toms subsided.21
Conventional CT scan is not useful preoperatively and
it can also be normal in postoperatively symptomatic pa-
tients. CT findings, such as diffuse or patchy white-matter
edema, mass effect, and petechial or massive ipsilateral
hemorrhages ipsilateral to CEA, are considered to be cor-
related with CHS. Single-photon emission CT (SPECT)
can detect alterations in brain perfusion and the impair-
ment of preoperative cerebrovascular reactivity (after acet-
azolamide). It is a sensitive method for recognizing CHS,
differentiating between ischemia and hyperperfusion and
identifying patients at risk for hyperperfusion after
CEA.17,57,67 A diffuse asymmetric pattern of preoperative
CBF reduction seems to be characteristic in these patients.
However Sfyroeras et al did not find an association between
preoperative asymmetry in brain perfusion in rest and
CHS.68 Ogasawara et al suggested that hyperperfusion
lasting at least to the three postoperative days on SPECT
predisposes to CHS development.69 Advanced imaging
processes and statistical analyses can further improve the
predictive value of this technique.18
Magnetic resonance techniques, such as multislice dy-
namic susceptibility contrast MRI or perfusion-weighted
MRI (PWI), can also be used in the preoperative CBF
assessment.70,71 Karapanayiotides et al reported no abnor-
malities on diffusion-weighted MRI, ruling out acute isch-
emia; in contrast, PWI revealed relative interhemispheric
CBF differences in patients with CHS after CEA.24 PWI,
however, is not a quantitative method and can only help in
the absence of contralateral ICA steno-occlusive disease.
Conventional MRI findings in patients with CHS include
white-matter edema, focal infarction, and local or massive
hemorrhage. These abnormalities, however, are not patho-
Fig. Algorithm for management of patients with symp
carotid revascularization.gnomonic for CHS.Alternative methods have been applied to identify risk
factors for postoperative hyperfusion, but their use is not
widespread and their utility for this indication is not yet
clearly established. Although electroencephalogram is
widely used for neurological monitoring during CEA, it is
of low predictive value for CHS.27 Ocular pneumoplethys-
mography has also been used to predict post-CEA CHS.
Nicholas et al reported that a postoperative increase of
ocular blood flow greater than 204% is associated with a
high risk for CHS.72 Transcranial color-coded real-time
ultrasonography with echo contrast agents is another
method that has been assessed for the diagnosis of hyper-
perfusion and prediction of CHS following CEA. A 1.5-
fold postoperative increase of MCA mean flow velocity
(MFV) compared with preoperative levels yielded high
accuracy predictions of CHS.73 Recent studies have pro-
posed that transcranial regional cerebral oxygen saturation
estimated by near-infrared spectroscopy can indicate CBF
changes detecting hyperperfusion following CEA.74,75
However, this technique has several technical limitations
that should be surmounted in order to improve its sensitiv-
ity and specificity in the diagnosis of post-CEA hyperfusion.
MANAGEMENT OF HYPERPERFUSION
SYNDROME
There are no data from randomized trials comparing
the optimal perioperative management protocol for pa-
tients with CHS, due to the rarity of this complication.
Intracranial hemorrhage as part of a hyperperfusion syn-
drome is associated with a poor prognosis. Therefore pre-
vention is critical and is based on recognition of vulnerable
patients at risk for developing CHS based upon pre-, peri-,
or postoperative criteria.10,76,77 In patients with raised
suspicion of CHS, prompt diagnosis and initiation of ap-
suggestive of cerebral hyperperfusion syndrome aftertomspropriate treatment is crucial (Fig).
JOURNAL OF VASCULAR SURGERY
April 20091066 Moulakakis et alIntensive hemodynamic monitoring, including control
of systemic blood pressure and use of TCD postoperatively
to assess CBF changes, is believed to play a significant role
in the prevention of the syndrome.4,9 Many authors sug-
gest that postoperative blood pressures should be main-
tained to normal or slight subnormal values, a point that
seems obvious and reasonable based on the pathophysiol-
ogy of the syndrome.4,9 However, the syndrome may also
be developed in normotensive patients or in subjects with
levels of systolic pressure minor of 160 mmHg, reflecting
the role of impaired autoregulatory mechanisms.10,21,78,79
Consensus consists in that the extent of the symptoms may
be limited by intensive blood pressure control, even if the
patient’s pressure is “normal.”80 There is no definitive
evidence favoring any particular antihypertensive drug
and indicative levels of systolic pressure. It has been
proposed that cerebral vasodilating medication with di-
hydralazin, nitrate or calcium channel antagonists should
be avoided on the basis of intensifying the brain edema
although reducing the systolic blood pressure.5 In addi-
tion, -blocker drugs could be limited due to aggravation
of a potential induced bradycardia after revascularization.
There are no available data recommending prophylac-
tic use of anticonvulsant therapy in patients undergoing
carotid revascularization.2,81 Reigel, in an old study, con-
sidered prophylaxis when periodic lateralized epileptiform
discharges are present on EEG.27 However, in the presence
of seizures, treatment with anticonvulsants is always indi-
cated.
In a study by Ogasawara pretreatment with edaravone
(60 mg in 100 mL physiological saline intravenously, 30
minutes immediately before internal carotid-artery clamp-
ing) decreased the incidence of carotid endarterectomy
hyperperfusion as measured by single-photon-emission
CT.82 Additionally, Kusmic suggested that cerebral oxida-
tive stress associated with carotid endarterectomy can be
attenuated by pretreatment with oral dipyridamole.83
However, further trials are warranted to support the benefit
of these agents.
Cerebral edema treatment, which includes adequate
sedation, hyperventilation, administration of mannitol, or
hypertonic saline, may also be effective.16,56,69,74 Cortico-
steroids and barbiturates have also been used in CHS but
their effectiveness in clinical outcome remains uncer-
tain.16,56,69,74
Modern clinical guidelines suggest a short hospital stay
while in case of CAS patients are discharged within 24 to 48
hours. Family doctors should be aware of the possible
delayed CHS and tend to monitor and treat an increased
and uncontrolled blood pressure.69 Once patients are dis-
charged, they should be advised to return to the hospital if
they develop a severe headache within the first weeks of
surgery.
SUMMARY
Cerebral hyperperfusion syndrome is a serious compli-
cation of carotid revascularization, including carotid end-
arterectomy and carotid stent placement. Two interlinkedand synergistic mechanisms may lead to development of
syndrome; impaired cerebral autoregulation and postoper-
atively elevated systemic blood pressure. Although clinical
studies have identified potential risk factors, definitive pre-
diction of subgroups of patients as those at increased risk of
developing CHS after CEA or CAS is not feasible. CHS, if
not treated properly, can result in severe brain oedema,
intracerebral hemorrhage, or death. Treatment strategies
are directed towards regulation of blood pressure and lim-
itation of rises in cerebral perfusion.
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